Three New Regions on Chromosome 17p13.3 Distal to p53 with Possible Tumor Suppressor Gene Involvement in Lung Cancer (original) (raw)

Abstract

We investigated loss of heterozygosity (LOH) at the distal portion of the p53 gene on the short arm of chromosome 17 in lung cancers in order to search for new tumor suppressor genes. The roles of the putative genes were also studied in terms of pathological features. One hundred and forty‐five resected non‐small cell lung cancers were examined for LOH using 11 markers mapped on, and distal to the p53 locus, and deletion maps were constructed. Four commonly deleted regions were found: one from TP53 to ENO3, where the p53 gene resides, and three others from ENO3 to D17S1566, D17S379 to D17S1574 and distal to ABR, with LOH frequencies almost the same as, or higher than, at the TP53 locus. Examination of the relationship between LOH of the latter three regions and histopathological parameters of adenocarcinomas (genetically negative for p53 mutation) revealed allelic losses on D17S379 to be associated with advanced lesions, while D17S513 was more frequently deleted in poorly differentiated tumors. These results indicate that new tumor suppressor gene(s) may reside on these three distinctly deleted regions on chromosome 17p13.3 distal to the p53 gene in lung cancer, with possible roles in progression and differentiation of adenocarcinomas.

Keywords: Tumor suppressor gene, 17p13.3, Non‐small cell lung cancer, LOH, Prognosis

Full Text

The Full Text of this article is available as a PDF (311.6 KB).

REFERENCES

• 1.) Ponder , B.Gene losses in human tumours . Nature , 335 , 400 – 402 ( 1988. ). [DOI] [PubMed] [Google Scholar]
• 2.) Yokota , J. , Wada , M. , Shimosato , Y. , Terada , M. and Sugimura , T.Loss of heterozygosity on chromosomes 3, 13, and 17 in small‐cell carcinoma and on chromosome 3 in adenocarcinoma of the lung . Proc. Natl. Acad. Sci. USA , 84 , 9252 – 9256 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
• 3.) Harbour , J. W. , Lai , S. L. , Whang‐Peng , J. , Gazdar , A. F. , Minna , J. D. and Kaye , F. J.Abnormalities in structure and expression of the human retinoblastoma gene in SCLC . Science , 241 , 353 – 357 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
• 4.) Takahashi , T. , Nau , M. M. , Chiba , I. , Birrer , M. , Rosenberg , R. K. , Vinocour , M. , Levitt , M. , Pass , H. , Gazder , A. F. and Minna , J.p53: a frequent target for genetic abnormalities in lung cancer . Science , 246 , 491 – 494 ( 1989. ). [DOI] [PubMed] [Google Scholar]
• 5.) Hayashi , N. , Sugimoto , Y. , Tsuchiya , E. , Ogawa , M. and Nakamura , Y.Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK41 (cyclin‐dependent kinase‐4 inhibitor) gene in human primary non‐small cell lung carcinomas . Biochem. Biophys. Res. Commun. , 202 , 1426 – 1430 ( 1994. ). [DOI] [PubMed] [Google Scholar]
• 6.) Kamb , A. , Gruis , N. A. , Weaver‐Feldhaus , J. , Liu , Q. , Harshman , K. , Tavtigian , S. V. , Stockert , E. , Day , R. S.III , Johnson , B. E. and Skolnick , M. H.A cell cycle regulator potentially involved in genesis of many tumor types . Science , 264 , 436 – 440 ( 1994. ). [DOI] [PubMed] [Google Scholar]
• 7.) Tsuchiya , E. , Nakamura , Y. , Weng , S. Y. , Nakagawa , K. , Tsuchiya , S. , Sugano , H. and Kitagawa , T.Allelotype of non‐small cell lung carcinoma—comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma . Cancer Res. , 52 , 2478 – 2481 ( 1992. ). [PubMed] [Google Scholar]
• 8.) Sato , S. , Nakamura , Y. and Tsuchiya , E.Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung . Cancer Res. , 54 , 5652 – 5655 ( 1994. ). [PubMed] [Google Scholar]
• 9.) Morris , C. , Benjes , S. , Haataja , L. , Ledbetter , D. H. , Heisterkamp , N. and Groffen , J.Spatial organization of ABR and CRK genes on human chromosome band 17p13.3 . Oncogene , 10 , 1009 – 1011 ( 1995. ). [PubMed] [Google Scholar]
• 10.) Wales , M. M. , Biel , M. A. , Deiry , W. E. , Nelkin , B. D. , Issa , J.‐P. , Cavenee , W. K. , Kuerbitz , S. J. and Baylin , S. B.p53 activates expression of HIC‐1, a new candidate tumour suppressor gene on 17p13.3 . Nat. Med. , 1 , 570 – 577 ( 1995. ). [DOI] [PubMed] [Google Scholar]
• 11.) Schultz , D. C. , Vanderveer , L. , Berman , D. B. , Hamilton , T. C. , Wong , A. J. and Godwin , A. K.Identification of two candidate tumor suppressor genes on chromosome 17p13.3 . Cancer Res. , 56 , 1997 – 2002 ( 1996. ). [PubMed] [Google Scholar]
• 12.) World Health Organization . “Histological Typing of Lung Tumors. International Histological Classification of Tumors ,” 2nd Ed. , Vol. 1 , pp. 19 – 32 ( 1981. ). World Health Organization; , Geneva . [Google Scholar]
• 13.) International Union Against Cancer . “TNM Supplement 1993: A Commentary on Uniform Use ,” pp. 34 – 36 ( 1993. ). Springer‐Verlag; , Berlin . [Google Scholar]
• 14.) Hashimoto , T. , Tokuchi , Y. , Hayashi , M. , Kobayashi , Y. , Nishida , K. , Hayashi , S. , Ishikawa , Y. , Tsuchiya , S. , Nakagawa , K. , Hayashi , J. and Tsuchiya , E.p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early stage non‐small‐cell lung carcinomas . Cancer Res. , 59 , 5572 – 5577 ( 1999. ). [PubMed] [Google Scholar]
• 15.) Greenblatt , M. S. , Bennett , W. P. , Hollstein , M. and Harris , C. C.Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis . Cancer Res. , 54 , 4855 – 4878 ( 1994. ). [PubMed] [Google Scholar]
• 16.) Biegel , J. A. , Burk , C. D. , Barr , F. G. and Emanuel , B. S.Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors . Cancer Res. , 52 , 3391 – 3395 ( 1992. ). [PubMed] [Google Scholar]
• 17.) Saxena , A. , Clark , W. C. , Robertson , J. T. , Ikejiri , B. , Oldfield , E. H. and Ali , I. U.Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas . Cancer Res. , 52 , 6716 – 6721 ( 1992. ). [PubMed] [Google Scholar]
• 18.) Nishida , N. , Fukuda , Y. , Kokuryu , H. , Toguchida , J. , Yandell , D. W. , Ikenega , M. , Imura , H. and Ishizaki , K.Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma . Cancer Res. , 53 , 368 – 372 ( 1993. ). [PubMed] [Google Scholar]
• 19.) Isomura , M. , Tanigami , A. , Saito , H. , Harada , Y. , Katagiri , T. , Inazawa , J. , Ledbetter , D. H. and Nakamura , Y.Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high‐resolution physical map with 29 markers . Genes Chromosom. Cancer , 9 , 173 – 179 ( 1994. ). [DOI] [PubMed] [Google Scholar]
• 20.) Phillips , N. J. , Ziegler , M. R. , Radford , D. M. , Fair , K. L. , Steinbrueck , T. , Xynos , F. P. and Donis‐Keller , H.Allelic deletion on chromosome 17p13.3 in early ovarian cancer . Cancer Res. , 56 , 606 – 611 ( 1996. ). [PubMed] [Google Scholar]
• 21.) Chattopadhyay , P. , Rathore , A. , Mathur , M. , Sarkar , C. , Mahapatra , A. K. and Sinha , S.Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours . Oncogene , 15 , 871 – 874 ( 1997. ). [DOI] [PubMed] [Google Scholar]
• 22.) Haataja , L. , Raffel , C. , Ledbetter , D. H. , Tanigami , A. , Petersen , D. , Heisterkamp , N. and Groffen , J.Deletion within the D17S34 locus in a primitive neuroectodermal tumor . Cancer Res. , 57 , 32 – 37 ( 1997. ). [PubMed] [Google Scholar]
• 23.) Konishi , H. , Takahashi , T. , Kozaki , K. , Yatabe , Y. , Mitudomi , T. , Fujii , Y. , Sugiura , T. , Matsuda , H. , Takahashi , T. and Takahashi , T.Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers . Oncogene , 17 , 2095 – 2100 ( 1998. ). [DOI] [PubMed] [Google Scholar]
• 24.) Yokoyama , S. , Yamakawa , K. , Tsuchiya , E. , Murata , M. , Sakiyama , S. and Nakamura , Y.Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung . Cancer Res. , 52 , 873 – 877 ( 1992. ). [PubMed] [Google Scholar]
• 25.) White , G. R. M. , Stack , M. , Santibanez‐Koref , M. , Liscia , D. S. , Venesio , T. , Wang , J.‐C. , Helms , C. , Donis‐Keller , H. , Betticher , D. C. , Altematt , H. J. , Hoban , P. R. and Heighway , J.High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor . Br. J. Cancer , 74 , 863 – 870 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
• 26.) Meroni , G. , Reymond , A. , Alcalay , M. , Borsani , G. , Tanigami , A. , Tonlorenzi , R. , Nigr , C. L. , Messali , S. , Zollo , M. , Ledbetter , D. H. , Brent , R. , Ballabio , A. and Carrozzo , R.Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a noncanonical E box and acts as a transcriptional repressor . EMBO J. , 16 , 2892 – 2906 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
• 27.) Takahashi , T. , Konishi , H. , Kozaki , K. , Osada , H. , Saji , S. , Takahashi , T. and Takahashi , T.Molecular analysis of a myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers . Jpn. J. Cancer Res. , 89 , 347 – 351 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
• 28.) Apolinario , R. M. , van der Valk , P. , de Jong , J. S. , Deville , W. , van Ark‐Otte , J. , Dingemans , A.‐M. C. , van Mourik , J. C. , Postmus , P. E. , Pinedo , H. M. and Giaccone , G.Prognostic value of the expression of p53, bcl‐2, and bax oncoproteins, and neovascularization in patients with radically resected non‐small‐cell lung cancer . J. Clin. Oncol. , 15 , 2456 – 2466 ( 1997. ). [DOI] [PubMed] [Google Scholar]
• 29.) Esposito , V. , Baldi , A. , Luca , A. D. , Micheli , P. , Mazzarella , G. , Baldi , F. , Caputi , M. and Giordano , A.Prognostic value of p53 in non‐small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking . Hum. Pathol. , 28 , 233 – 237 ( 1997. ). [DOI] [PubMed] [Google Scholar]
• 30.) Esposito , V. , Baldi , A. , Luca , A. D. , Groger , A. M. , Loda , M. , Giordano , G. G. , Caputi , M. , Baldi , F. , Pagano , M. and Giordano , A.Prognostic role of the cyclin‐dependent kinase inhibitor p27 in non‐small cell lung cancer . Cancer Res. , 57 , 3381 – 3385 ( 1997. ). [PubMed] [Google Scholar]
• 31.) Higashiyama , M. , Doi , O. , Kodama , K. , Yokouchi , H. , Kasugai , T. , Ishiguro , S. , Takami , K. , Nakayama , T. and Nishisho , I.MDM2 gene amplification and expression in non‐small‐cell lung cancer: immunohistochemical expression of its protein is a favorable prognostic marker in patients without p53 protein accumulation . Br. J. Cancer , 75 , 1302 – 1308 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
• 32.) Strauss , G. M. , Kwiatkowski , D. J. , Harpole , D. H. , Lynch , T. J. , Skarin , A. T. and Sugarbaker , D. J.Molecular and pathologic markers in stage I non‐small‐cell carcinoma of the lung . J. Clin. Oncol. , 13 , 1265 – 1279 ( 1995. ). [DOI] [PubMed] [Google Scholar]